This syndicate will primarily focus on healthcare deals related to medtech, pharma, medical device, and medical marketplaces. We are focused on world changing businesses with the opportunity to scale at the pre-seed to Series B rounds.

Healthcare is ripe for disruption and our syndicate will search for companies with specific value adds to the healthcare system. We will avoid middleman opportunities to invest in traditional healthcare businesses. We search for companies that can scale to adjacent segments quickly, build scale, and high margins into their core model. Above all else, the companies must advance the human condition by reducing Costs, improving Quality, or increasing Access related to healthcare.

We obtain deal flow through industry contacts, partner accelerators, and co-sharing among other similarly focused SPVs.